Risk Aversion On Persistent Second Wave Fears, BoE Up Next
Fiona Cincotta June 18, 2020 3:48 PM
Fears of a second wave of covid-19 derailing the fragile economic recovery is dragging stocks lower. BoE in focus as central bank expected to increase asset purchase programme by £100 billion.
Fears of a second wave of coronavirus persisted overnight dragging on risk sentiment, pulling Asian markets lower and setting European bourses up for a lower start on the open.The number of cases in some US states are rising to record levels, which is unnerving investors. Texas, saw its largest daily increase in infections since the start of the coronavirus pandemic. However, it is worth keeping in mind that this is timing. Whilst states such as New York have passed the peak and are now reopening, some US states are experiencing the first wave of daily rises, just later. However, the chances of this spreading are still very real.
The BoE Is not expected to cut interest rates from the current 0.1% when it meets today. It is broadly expected to increase its Asset Purchase Programme by £100 billion. There is a good chance that some policy makers will be more dovish and push for a bigger increase.
Since the pandemic started the central bank has slashed rates from 0.75% to the 300 year low of 0.1%. It has also added £200 billion to its quantitative easing programme, taking the total to £645 billion.
US initial jobless claims a frustrating slow come down
Jobless claims are expected to increase by 1.3 million, down from the previous week’s 1.5 million. Whilst this will be the lowest increase in 3 months, it is still 6 x the pre-coronavirus February figure. Continuing claims are also expected to show a drop to 19.8 million, down from 20.9 million as starts slowly reopening and Americans are gradually rehired. The pace is frustratingly slow and suggests that another knockout month of retail sales is looking unlikely. A weak reading could feed risk aversion boosting USD and weighing on equities.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.